Skip to main content
Kidney360 logoLink to Kidney360
. 2020 Mar 6;1(3):225–226. doi: 10.34067/KID.0000092019

Unusual Cause for Continuous Renal Replacement Therapy Filter Clotting

Michael Whitlow 1, Arun Rajasekaran 1, Dana Rizk 1,
PMCID: PMC8809256  PMID: 35368629

Clinical Images in Nephrology and Dialysis

Case Answer

A 54-year-old woman presented with massive pulmonary thromboembolism. Catheter-directed thrombolysis was unsuccessful. Subsequent mechanical thrombectomy was complicated by cardiac arrest, and the patient required vasopressor and extracorporeal membrane oxygenation support. Given anuric kidney injury, continuous RRT (CRRT) was initiated. She had prolonged sedation with propofol, and on hospital day 15, she developed recurrent clotting on CRRT despite the use of adequate regional citrate anticoagulation. A lipoid substance in the tubing was noted as clogging the CRRT and extracorporeal membrane oxygenation circuits (Figure 1). Additionally, laboratory values showed worsening anion gap metabolic acidosis (serum HCO3: 14 mmol/L; anion gap: 20) with normal lactic acid (3.4 mmol/L). A diagnosis of propofol infusion syndrome was suspected, and serum triglycerides were checked and came back elevated at 1132 mg/dl (72 mg/dl on admission). Propofol was immediately stopped. The following day, serum triglyceride level dropped to 850 mg/dl, and no further clotting or lipoid material was noted. Propofol infusion syndrome is a rare but potentially fatal complication typically associated with high-dose infusion (>67 μg/kg per minute) for over 48 hours (1). However, as in this case, toxicity has also been reported with lower doses given over an extended period of time. Additional risk factors include critical illness, vasopressor use, and severe liver injury. Typical features include unexplained anion gap metabolic acidosis, hyperkalemia, hypertriglyceridemia, and cardiac dysrhythmias (2). Propofol is a lipid emulsion, and excessive doses of this lipid emulsion do not hydrolyze in the plasma, leading to elevated triglyceride levels (3). The exact mechanism as to how hypertriglyceridemia leads to CRRT clotting is not entirely elucidated, but some theories include hypertriglyceridemia leading to hyperviscosity as well as obstruction of the hemofilter fibers by lipoid material (4). Our patient illustrates an unusual manifestation of this rare entity that allowed prompt diagnosis and intervention, averting potentially fatal consequences.

Figure 1.

Figure 1.

Lipoid material noted clogging CCRT circuit. (A) Lipoid material in continuous RRT (CRRT) filter. (B) Lipoid material in CRRT deaeration chamber.

Teaching Points

  • Propofol infusion syndrome can be a rare cause for CRRT filter clotting.

  • Early recognition of propofol infusion syndrome is important to prevent potentially fatal complications.

Disclosures

M. Whitlow, A. Rajasekaran, and D. Rizk have nothing to disclose.

Author Contributions

M. Whitlow, A. Rajasekaran, and D. Rizk wrote the original draft, and reviewed and edited the manuscript.

References

  • 1.Mirrakhimov AE, Voore P, Halytskyy O, Khan M, Ali AM: Propofol Infusion Syndrome in Adults: A Clinical Update. Critical Care Research and Practice 2015: 1–10, 2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kam PC, Cardone D: Propofol infusion syndrome. Anaesthesia 62: 690–701, 2007 [DOI] [PubMed] [Google Scholar]
  • 3.Kaur H, Nattanamai P, Qualls KE: Propofol and clevidipine-induced hypertriglyceridemia. Cureus 10: e3165, 2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.McLaughlin DC, Fang DC, Nolot BA, Guru PK: Hypertriglyceridemia causing continuous renal replacement therapy dysfunction in a patient with end-stage liver disease. Indian J Nephrol 28: 303–306, 2018 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Kidney360 are provided here courtesy of American Society of Nephrology

RESOURCES